Borage Oil (Starflower Oil)

Borago officinalis
Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Borage oil is cold-pressed from BORAGE SEEDS (Borago officinalis, also known as 'starflower') — distinguished as having the HIGHEST KNOWN CONCENTRATION OF GAMMA-LINOLENIC ACID (GLA, ~20-26%) of any commercial plant oil, surpassing evening primrose (~9%) and black currant (~15%). Used for atopic dermatitis, rheumatoid arthritis, premenstrual syndrome, and other conditions where GLA's anti-inflammatory effects are sought. CRITICAL: contains pyrrolizidine alkaloids (PAs) — hepatotoxic; reputable products are PA-tested/certified PA-free.

Studied Dose 1-3 g borage oil/day (providing 240-720 mg GLA daily); RA trials used up to 1.4 g GLA/day
Active Compound Gamma-linolenic acid (GLA, 20-26% of oil)

Benefits

Highest GLA Concentration of Plant Oils

Distinguishes borage from evening primrose (~9% GLA) and black currant (~15% GLA). Lower volume of borage oil needed for equivalent GLA dose. Cost-effective GLA source per dose.

Rheumatoid Arthritis Adjunct

Multiple trials (Leventhal 1993, others) show GLA from borage oil (1.4 g/day) reduces joint pain, morning stiffness, and NSAID requirements in RA. Adjunct to standard treatment. Effect smaller than fish oil EPA/DHA but documented.

Atopic Dermatitis / Eczema (Mixed Evidence)

Earlier trials suggested benefit; larger systematic review (Bamford 2013) of 27 trials found GLA (from borage and evening primrose) NOT effective for atopic dermatitis. Current consensus: limited/no benefit despite long-standing folk use.

Premenstrual Syndrome Support

Some evidence for cyclic mastalgia and PMS symptoms. Effects modest; foundational evidence from older trials less robust by modern standards.

Diabetic Neuropathy Adjunct

Older research suggested GLA may help diabetic neuropathy. Modern evidence less robust; alpha-lipoic acid has stronger evidence for this indication.

Mechanism of action

1

GLA → DGLA → PGE1 Anti-Inflammatory Pathway

GLA (gamma-linolenic acid) is metabolized via elongase to DGLA (dihomo-gamma-linolenic acid), which produces SERIES-1 PROSTAGLANDINS (PGE1) — anti-inflammatory, anti-platelet, vasodilatory. Distinguishes from arachidonic acid pathway producing pro-inflammatory PGE2. Mechanism for anti-inflammatory effects.

2

Bypass Delta-6 Desaturase Limitation

Conversion of LA to GLA requires DELTA-6 DESATURASE — limited in: aging, diabetes, alcohol use, deficiency states. Direct GLA supplementation bypasses this conversion bottleneck. Theoretical advantage in those with reduced conversion capacity.

3

Skin Barrier Lipid Support

GLA contributes to skin barrier lipid composition; theoretical benefit for skin conditions (though clinical evidence limited for eczema).

4

Cytokine Modulation

GLA modulates pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6) via DGLA-derived eicosanoids and direct effects.

Clinical trials

1
Borage Oil for Rheumatoid Arthritis — Leventhal 1993
PubMed

RCT of borage oil GLA (1.4 g GLA/day) vs placebo in 37 RA patients for 24 weeks.

37 RA patients.

GLA group had significant improvements in joint tenderness, swelling, and morning stiffness. Established borage oil as RA adjunct. Adjunct only — not replacement for DMARDs/biologics.

2
GLA for Atopic Dermatitis — Systematic Review (Bamford 2013)
PubMed

Systematic review/meta-analysis of 27 RCTs of borage and evening primrose oil for atopic dermatitis.

Pooled across 27 RCTs.

GLA NOT effective for atopic dermatitis. Despite long folk use, RCT evidence does not support benefit. Notable example of folk medicine claims not surviving rigorous evaluation.

About this ingredient

About the active ingredient

BORAGE OIL is COLD-PRESSED OIL from BORAGE SEEDS (BORAGO OFFICINALIS — also called 'STARFLOWER' for its blue star-shaped flowers). Native to Mediterranean region; cultivated worldwide. Distinguished as having the HIGHEST KNOWN CONCENTRATION OF GLA among commercial plant oils (~20-26%, vs ~9% evening primrose, ~15% black currant).

KEY ACTIVE: GAMMA-LINOLENIC ACID (GLA) — an omega-6 fatty acid that bypasses the delta-6 desaturase enzyme bottleneck in conversion of LA to anti-inflammatory eicosanoid precursors.

EVIDENCE-BASED USES: (1) RHEUMATOID ARTHRITIS adjunct (Leventhal 1993 et al.); (2) Atopic dermatitis / eczema — POPULAR USE BUT NOT SUPPORTED by 2013 systematic review; (3) Premenstrual syndrome / cyclic mastalgia (older evidence, less robust by modern standards); (4) Diabetic neuropathy (older evidence; alpha-lipoic acid more established); (5) GLA supplementation for delta-6 desaturase-deficient populations; (6) Cardiovascular adjunct (modest evidence).

CRITICAL CAUTIONS: (1) PYRROLIZIDINE ALKALOID (PA) CONTAMINATION — borage plant naturally contains pyrrolizidine alkaloids (especially amabiline, lycopsamine, supinine) which are HEPATOTOXIC at chronic exposure; processing CAN reduce but not eliminate PAs; reputable products test for PAs and certify 'PA-free' or specify <1 ppm; AVOID UNTESTED BORAGE PRODUCTS; alternative GLA sources (evening primrose oil) don't have this issue; (2) PREGNANCY/LACTATION — PA risk for fetal/neonatal liver; AVOID without obstetric guidance; some sources also raise concerns about prostaglandin effects in late pregnancy (theoretical preterm labor); (3) SEIZURE THRESHOLD — older case reports of borage oil and other GLA sources lowering seizure threshold, especially in combination with phenothiazines or in epileptics; AVOID with: epilepsy, phenothiazine medications; (4) HEPATOTOXIC MEDICATION COMBINATION — PA risk amplified; AVOID with hepatotoxic drugs; (5) BLEEDING RISK — modest antiplatelet effects via prostaglandin modulation; pre-surgery discontinuation; (6) DOSE — 1-3 g borage oil/day providing 240-720 mg GLA; RA trials used up to 1.4 g GLA/day; effect builds over weeks-months; (7) BORAGE VS EVENING PRIMROSE VS BLACK CURRANT — BORAGE: highest GLA content but PA concerns; EVENING PRIMROSE: lower GLA, no PA concerns, more research history (especially eczema); BLACK CURRANT: includes both GLA and SDA (stearidonic acid, omega-3); choice depends on application and PA tolerance; (8) ATOPIC DERMATITIS DISCREPANCY — folk and integrative use widespread; rigorous RCT evidence fails to support; possible explanations: placebo response, regression to the mean, inadequate doses in trials, inappropriate populations; current evidence-based recommendation is NOT to use GLA for atopic dermatitis specifically; (9) STORAGE — refrigerate after opening; protect from light/heat; oxidation creates rancid product; (10) FOR RHEUMATOID ARTHRITIS — borage oil GLA is reasonable adjunct alongside DMARDs and biologics; not replacement; effect smaller than fish oil EPA/DHA for joint symptoms; (11) DELTA-6 DESATURASE DEFICIENCY — theoretical group benefiting most: those with reduced LA→GLA conversion (older adults, diabetics, chronic alcohol users, atopic individuals); evidence for differential benefit limited; (12) BORAGE LEAVES / FLOWERS — different from oil; contain higher PA concentrations; AVOID culinary use of borage flowers/leaves except in trace amounts (some traditional use as garnish); (13) The PA issue is the most distinguishing concern for borage vs other GLA sources; for most users, evening primrose oil provides safer GLA without the PA concern.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress (nausea, soft stools).
Headache rare.
PYRROLIZIDINE ALKALOID (PA) CONCERN — borage plant contains hepatotoxic PAs; reputable products test/certify PA-free; AVOID untested products.
Theoretical seizure threshold lowering (older case reports of seizures in epileptics at very high doses).
Bleeding risk theoretical (modest).

Important Drug interactions

ANTICOAGULANTS — additive bleeding risk theoretical; minor.
PHENOTHIAZINES (chlorpromazine, prochlorperazine) — case reports of seizure threshold lowering; AVOID combination.
Anticonvulsants — theoretical seizure risk; consult.
Hepatotoxic medications — pyrrolizidine alkaloid risk amplified; choose PA-tested products.
Pregnancy — limited safety data; PA risk for fetus; AVOID without obstetric guidance.
Lactation — PAs may transfer to breast milk; AVOID without medical guidance.
Pre-surgery — discontinue 1-2 weeks before.

Frequently asked questions about Borage Oil (Starflower Oil)

What is the recommended dosage of Borage Oil (Starflower Oil)?

The clinically studied dose for Borage Oil (Starflower Oil) is 1-3 g borage oil/day (providing 240-720 mg GLA daily); RA trials used up to 1.4 g GLA/day. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Borage Oil (Starflower Oil) used for?

Borage Oil (Starflower Oil) is studied for highest gla concentration of plant oils, rheumatoid arthritis adjunct, atopic dermatitis / eczema (mixed evidence). Distinguishes borage from evening primrose (~9% GLA) and black currant (~15% GLA). Lower volume of borage oil needed for equivalent GLA dose. Cost-effective GLA source per dose.

Are there side effects from taking Borage Oil (Starflower Oil)?

Reported potential side effects may include: Generally well-tolerated. Mild GI distress (nausea, soft stools). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Borage Oil (Starflower Oil) interact with medications?

Known drug interactions may include: ANTICOAGULANTS — additive bleeding risk theoretical; minor. PHENOTHIAZINES (chlorpromazine, prochlorperazine) — case reports of seizure threshold lowering; AVOID combination. Consult a pharmacist or healthcare provider if you take prescription medications.

Is Borage Oil (Starflower Oil) good for skin health?

Yes, Borage Oil (Starflower Oil) is researched for Skin Health support. Distinguishes borage from evening primrose (~9% GLA) and black currant (~15% GLA). Lower volume of borage oil needed for equivalent GLA dose. Cost-effective GLA source per dose.